A detailed history of Pacific Sage Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pacific Sage Partners, LLC holds 4,122 shares of JNJ stock, worth $615,950. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,122
Previous 4,122 -0.0%
Holding current value
$615,950
Previous $646 Million 0.94%
% of portfolio
0.17%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $145 - $158
1 Added 0.02%
4,122 $646 Million
Q3 2023

Oct 30, 2023

BUY
$155.75 - $174.48 $155 - $174
1 Added 0.02%
4,121 $642 Million
Q2 2023

Jul 20, 2023

SELL
$154.35 - $166.11 $1,234 - $1,328
-8 Reduced 0.19%
4,120 $682 Million
Q1 2023

May 02, 2023

SELL
$151.05 - $180.26 $35,345 - $42,180
-234 Reduced 5.36%
4,128 $640 Million
Q4 2022

Jan 31, 2023

BUY
$160.2 - $179.79 $698,792 - $784,243
4,362 New
4,362 $771 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $391B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pacific Sage Partners, LLC Portfolio

Follow Pacific Sage Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Sage Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Sage Partners, LLC with notifications on news.